Xcel Wealth Management LLC purchased a new stake in shares of Oracle Corporation (NYSE:ORCL - Free Report) during the second quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm purchased 1,450 shares of the enterprise software provider's stock, valued at approximately $317,000.
A number of other hedge funds and other institutional investors have also recently modified their holdings of ORCL. Redmont Wealth Advisors LLC bought a new position in Oracle during the first quarter valued at approximately $27,000. Inlight Wealth Management LLC purchased a new stake in shares of Oracle in the 1st quarter valued at $28,000. Iron Horse Wealth Management LLC boosted its stake in shares of Oracle by 284.9% in the 1st quarter. Iron Horse Wealth Management LLC now owns 204 shares of the enterprise software provider's stock valued at $29,000 after purchasing an additional 151 shares in the last quarter. Graybill Wealth Management LTD. bought a new position in shares of Oracle during the 1st quarter valued at $39,000. Finally, Operose Advisors LLC raised its position in Oracle by 50.2% in the 1st quarter. Operose Advisors LLC now owns 314 shares of the enterprise software provider's stock worth $44,000 after purchasing an additional 105 shares during the period. 42.44% of the stock is currently owned by hedge funds and other institutional investors.
Oracle Trading Down 1.6%
NYSE ORCL opened at $308.86 on Thursday. The stock has a market cap of $877.69 billion, a P/E ratio of 71.50, a price-to-earnings-growth ratio of 3.39 and a beta of 1.46. Oracle Corporation has a fifty-two week low of $118.86 and a fifty-two week high of $345.72. The stock has a 50 day simple moving average of $256.58 and a two-hundred day simple moving average of $198.50. The company has a debt-to-equity ratio of 3.33, a quick ratio of 0.62 and a current ratio of 0.62.
Oracle (NYSE:ORCL - Get Free Report) last announced its earnings results on Tuesday, September 9th. The enterprise software provider reported $1.47 EPS for the quarter, missing analysts' consensus estimates of $1.48 by ($0.01). Oracle had a net margin of 21.08% and a return on equity of 72.93%. The business had revenue of $14.93 billion for the quarter, compared to the consensus estimate of $15.04 billion. During the same quarter in the prior year, the company earned $1.39 EPS. Oracle's revenue was up 12.2% compared to the same quarter last year. Oracle has set its Q2 2026 guidance at 1.270-1.310 EPS. On average, analysts forecast that Oracle Corporation will post 5 earnings per share for the current year.
Oracle Announces Dividend
The business also recently announced a quarterly dividend, which will be paid on Thursday, October 23rd. Stockholders of record on Thursday, October 9th will be paid a dividend of $0.50 per share. The ex-dividend date of this dividend is Thursday, October 9th. This represents a $2.00 dividend on an annualized basis and a dividend yield of 0.6%. Oracle's payout ratio is presently 46.30%.
Insider Activity at Oracle
In other Oracle news, insider Clayton M. Magouyrk sold 21,241 shares of Oracle stock in a transaction that occurred on Friday, September 12th. The stock was sold at an average price of $297.11, for a total transaction of $6,310,913.51. Following the sale, the insider directly owned 78,000 shares of the company's stock, valued at approximately $23,174,580. The trade was a 21.40% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, insider Michael D. Sicilia sold 33,845 shares of the company's stock in a transaction that occurred on Tuesday, September 23rd. The stock was sold at an average price of $321.16, for a total value of $10,869,660.20. Following the transaction, the insider owned 132,656 shares in the company, valued at $42,603,800.96. This trade represents a 20.33% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 112,092 shares of company stock valued at $32,960,165 over the last three months. Corporate insiders own 42.20% of the company's stock.
Analyst Upgrades and Downgrades
Several research firms have issued reports on ORCL. The Goldman Sachs Group upped their price target on shares of Oracle from $195.00 to $310.00 and gave the company a "neutral" rating in a research report on Monday, September 15th. Piper Sandler boosted their target price on Oracle from $270.00 to $330.00 and gave the company an "overweight" rating in a research note on Wednesday, September 10th. Bank of America upgraded Oracle from a "neutral" rating to a "buy" rating and increased their target price for the company from $295.00 to $368.00 in a report on Wednesday, September 10th. UBS Group set a $300.00 price target on Oracle in a research note on Wednesday, September 10th. Finally, Oppenheimer reiterated an "outperform" rating on shares of Oracle in a research report on Wednesday, June 18th. Two equities research analysts have rated the stock with a Strong Buy rating, twenty-five have issued a Buy rating and nine have given a Hold rating to the stock. According to MarketBeat, the company presently has an average rating of "Moderate Buy" and an average price target of $305.75.
View Our Latest Report on Oracle
Oracle Company Profile
(
Free Report)
Oracle Corporation offers products and services that address enterprise information technology environments worldwide. Its Oracle cloud software as a service offering include various cloud software applications, including Oracle Fusion cloud enterprise resource planning (ERP), Oracle Fusion cloud enterprise performance management, Oracle Fusion cloud supply chain and manufacturing management, Oracle Fusion cloud human capital management, Oracle Cerner healthcare, Oracle Advertising, and NetSuite applications suite, as well as Oracle Fusion Sales, Service, and Marketing.
Recommended Stories
Want to see what other hedge funds are holding ORCL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Oracle Corporation (NYSE:ORCL - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Oracle, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Oracle wasn't on the list.
While Oracle currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.